These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12049486)

  • 1. Ocular tolerance of absorption enhancers in ophthalmic preparations.
    Furrer P; Mayer JM; Plazonnet B; Gurny R
    AAPS PharmSci; 2002; 4(1):E2. PubMed ID: 12049486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biological availability of ophthalmic drugs. 1. Increasing drug permeability in the cornea].
    Masteiková R; Chalupová Z; Savickiene N
    Ceska Slov Farm; 2004 Mar; 53(2):73-9. PubMed ID: 15095575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oleic acid on the corneal permeability of compounds and evaluation of its ocular irritation of rabbit eyes.
    Gao XC; Qi HP; Bai JH; Huang L; Cui H
    Curr Eye Res; 2014 Dec; 39(12):1161-8. PubMed ID: 24749683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of ocular permeability of peptide drugs by absorption promoters.
    Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
    Biol Pharm Bull; 2000 Dec; 23(12):1524-7. PubMed ID: 11145191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octa-arginine modified lipid emulsions as a potential ocular delivery system for disulfiram: A study of the corneal permeation, transcorneal mechanism and anti-cataract effect.
    Liu C; Lan Q; He W; Nie C; Zhang C; Xu T; Jiang T; Wang S
    Colloids Surf B Biointerfaces; 2017 Dec; 160():305-314. PubMed ID: 28950195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of absorption promoters on corneal and conjunctival penetration of ophthalmic beta-blockers.
    Sasaki H; Igarashi Y; Nagano T; Nishida K; Nakamura J
    Pharm Res; 1995 Aug; 12(8):1146-50. PubMed ID: 7494826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancer effects on in vitro corneal permeation of timolol and acyclovir.
    Montenegro L; Bucolo C; Puglisi G
    Pharmazie; 2003 Jul; 58(7):497-501. PubMed ID: 12889536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ophthalmic preservatives as absorption promoters for ocular drug delivery.
    Sasaki H; Nagano T; Yamamura K; Nishida K; Nakamura J
    J Pharm Pharmacol; 1995 Sep; 47(9):703-7. PubMed ID: 8583378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery.
    Kaur IP; Smitha R
    Drug Dev Ind Pharm; 2002 Apr; 28(4):353-69. PubMed ID: 12056529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants.
    Furrer P; Plazonnet B; Mayer JM; Gurny R
    Int J Pharm; 2000 Oct; 207(1-2):89-98. PubMed ID: 11036234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased corneal hydration induced by potential ocular penetration enhancers: assessment by differential scanning calorimetry (DSC) and by desiccation.
    Monti D; Chetoni P; Burgalassi S; Najarro M; Saettone MF
    Int J Pharm; 2002 Jan; 232(1-2):139-47. PubMed ID: 11790497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intracanalicular collagen implants on the absorption of topically applied sodium fluorescein.
    Unterman SR; Reidy JJ; Hill JH; Kaufman HE
    Cornea; 1991 Nov; 10(6):516-8. PubMed ID: 1782780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of benzalkonium chloride/EDTA on the ocular bioavailability of ketorolac tromethamine following ocular instillation to normal and de-epithelialized corneas of rabbits.
    Madhu C; Rix PJ; Shackleton MJ; Nguyen TG; Tang-Liu DD
    J Pharm Sci; 1996 Apr; 85(4):415-8. PubMed ID: 8901080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limits on optimizing ocular drug delivery.
    Keister JC; Cooper ER; Missel PJ; Lang JC; Hager DF
    J Pharm Sci; 1991 Jan; 80(1):50-3. PubMed ID: 2013850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal penetration and ocular bioavailability of drugs.
    Burstein NL; Anderson JA
    J Ocul Pharmacol; 1985; 1(3):309-26. PubMed ID: 3916851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular pharmacokinetics and availability of topically applied baicalein in rabbits.
    Zhang L; Zhang J; Wang L; Xia H
    Curr Eye Res; 2009 Apr; 34(4):257-63. PubMed ID: 19373573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.
    Liu R; Liu Z; Zhang C; Zhang B
    J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of ophthalmic formulations containing cilostazol as an anti-glaucoma agent and improvement in its permeability through the rabbit cornea.
    Okamoto N; Ito Y; Nagai N; Murao T; Takiguchi Y; Kurimoto T; Mimura O
    J Oleo Sci; 2010; 59(8):423-30. PubMed ID: 20625234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
    Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
    Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of various concentrations of terpene-4-ol enhancer and carbopol-934 mucoadhesive upon the in vitro ocular transport and the in vivo intraocular pressure lowering effects of dorzolamide ophthalmic formulations using albino rabbits.
    Afouna MI; Khedr A; Abdel-Naim AB; Al-Marzoqi A
    J Pharm Sci; 2010 Jan; 99(1):119-27. PubMed ID: 19530071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.